DV

David Vidal

Chief Technology Officer

PharmEnable

Barcelona, Catalonia


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
PharmEnable
Industry
research
Employees
21.0
Seniority
C suite
Total Funding
9729668.0
Latest Funding
Other

Technologies

Outlook Microsoft Office 365 Google Cloud Hosting Google Font API Nginx Mobile Friendly Google Tag Manager WordPress.org reCAPTCHA

Keywords

biotechnology research drug discovery small molecules ai drug discovery medicinal chemistry cancer therapeutics neurodegenerative diseases gpcr targets molecular modeling chemical diversity inaccessible targets therapeutic innovation protein structure design oral small molecules novel drug candidates synthetic feasibility small molecule design collaborative drug discovery multi-dimensional chemical space bioavailability lead optimization clinical development structurally diverse molecules pharmaceutical research targeted therapy biologic specificity preclinical pipeline machine learning computational chemistry advanced drug design scientific expertise collaboration novel chemical space strategic partnerships biotech innovation clinical candidate selection drug design methodologies medicinal chemistry expertise technology collaboration therapeutic development drug repurposing diversity-oriented synthesis multidisciplinary approach chemical research custom drug design high-quality leads pharmaceutical collaborations clinical trials artificial intelligence information technology & services health care health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans